COR vs HSIC vs ZSTK Stock Comparison

Cencora, Henry Schein and ZeroStack Prices as of Oct 26, 2026 Peers: Industry group
COR Cencora, Inc.
$330.24 +7.6% 1M -0.7% 1Y
Market cap
$63.35B
P/E
24.1x
Revenue (TTM)
$332.77B
Div. yield
0.01%
Drug Distribution Healthcare
3 wins
HSIC Henry Schein Inc
$84.51 -2.2% 1M +32.4% 1Y
Market cap
$9.51B
P/E
23.6x
Revenue (TTM)
$13.60B
Div. yield
–
Drug Distribution Healthcare
6 wins
ZSTK ZeroStack Corp.
$3.13 -23.1% 1M -76.5% 1Y
Market cap
$30.48M
P/E
–
Revenue (TTM)
$40.03M
Div. yield
–
Drug Distribution Healthcare
2 wins

Head to Head

11 decided of 12

Henry Schein leads on 6 of the 12 questions below (Henry Schein 6, Cencora 3, ZeroStack 2). Which ones matter depends on what you are buying for; a cheap multiple and slow growth often come together.

QuestionCORHSICZSTKLeader
Larger companyMarket capitalisation $63.35B $9.51B $30.48M COR
Cheaper on earningsLower P/E, profitable companies only 24.1x 23.6x -0.2x HSIC
Cheaper on forward earningsLower price / next fiscal year consensus EPS 19.3x 14.7x — HSIC
Faster revenue growthRevenue growth, trailing twelve months +5.1% +6.5% +27.3% ZSTK
More profitableNet margin, trailing twelve months 0.8% 3.0% -444.3% HSIC
Better return on capitalReturn on invested capital 14.4% 7.1% -852.2% COR
Less leveragedLower net debt / EBITDA 2.2x 3.3x 0.0x ZSTK
Higher dividend yieldTrailing dividend yield 0.01% 0.00% 0.00% –
Better 1-year returnPrice return, last 12 months -0.7% +32.4% -76.5% HSIC
Better 5-year returnAnnualised price return, 5 years +22.6%/yr +2.6%/yr -75.0%/yr COR
Less volatileAnnualised volatility, 1 year 32.8% 25.7% 170.0% HSIC
Higher overall scoreMean of the five percentile scores vs peers 51/100 56/100 27/100 HSIC

Percentile Scorecard

CORHSICZSTK

Each axis is the mean percentile of its metrics against the company's industry group. 100 is the best in the group, 50 the middle.

Scores by Axis

AxisCORHSICZSTK
Valuation 54 #12 of 25 38 #16 of 25 17 #21 of 25
Growth 74 #7 of 24 39 #15 of 24 48 #13 of 24
Profitability 57 #11 of 24 83 #5 of 24 9 #22 of 24
Financial Health 24 #20 of 26 20 #21 of 26 60 #11 of 26
Shareholder Returns 47 #9 of 16 100 #1 of 16 0 #16 of 16
Overall 51 56 27
  • COR ranked among 27 companies in Healthcare Payers and Distributors
  • HSIC ranked among 27 companies in Healthcare Payers and Distributors
  • ZSTK ranked among 27 companies in Healthcare Payers and Distributors

Price Performance

Price return, split-adjusted, before dividends. Click a name to hide or show it.

Returns

PeriodCORHSICZSTKSPY
1 month +7.6%-2.2%-23.1% -0.8%
3 months +6.1%-0.1%+120.4% +3.5%
6 months +6.5%+9.5%-55.8% +7.0%
Year to date -2.2%+11.8%-50.0% +12.2%
1 year -0.7%+32.4%-76.5% +13.0%
3 years +76.0%+27.3%-88.0% +86.3%
3 years, per year +20.8%+8.4%-50.7% +23.1%
5 years +176.2%+13.9%-99.9% +68.6%
5 years, per year +22.6%+2.6%-75.0% +11.0%
10 years +316.1%+44.7%— +258.0%
10 years, per year +15.3%+3.8%— +13.6%

Risk

MeasureCORHSICZSTKSPY
Volatility, 1Y 32.8%25.7%170.0% 12.7%
Downside volatility, 1Y 39.6%24.1%132.8% 12.7%
Beta vs S&P 500, 1Y -0.150.461.68 1.00
Return / volatility, 1Y -0.021.26-0.45 1.02
Max drawdown, 5Y -32.6%-32.7%-100.0% -25.4%
From 52-week high -11.9%-7.0%-73.5% -1.8%
52-week high $374.75$90.86$11.80 $779.14
52-week low $252.74$62.32$1.37 $631.97

Valuation History

Weekly multiples on trailing twelve-month fundamentals. Negative or extreme readings (a loss year, a collapsed denominator) are left out so the chart stays readable.

MultipleCORHSICZSTK
P/E now vs peer median 24.3xmedian 24.3x 23.8xmedian 24.3x -0.2xmedian 24.3x
P/S now vs peer median 0.2xmedian 0.3x 0.7xmedian 0.3x 0.8xmedian 0.3x
EV/EBITDA now vs peer median 17.5xmedian 13.5x 12.7xmedian 13.5x -0.1xmedian 13.5x
P/FCF now vs peer median 15.5xmedian 15.6x 16.6xmedian 15.6x -5.5xmedian 15.6x
P/B now vs peer median 19.5xmedian 2.5x 2.5xmedian 2.5x 2.3xmedian 2.5x
PEG now vs peer median 1.36median 1.33 49.82median 1.33 0.00median 1.33

Financial History

Reported figures by fiscal period, placed on the calendar year (or quarter) each period ended in, so companies with different fiscal years line up.

Trailing twelve monthsCORHSICZSTK
Revenue $332.77B $13.60B $40.03M
Gross profit $13.22B $4.26B $5.26M
Operating income $3.04B $680.00M -$239.39M
Net income $2.65B $426.00M -$177.88M
Free cash flow $4.06B $569.00M -$5.64M
EPS (diluted) $13.53 $3.52 $-17.86
Cash & equivalents $2.82B – $2.64M
Total debt $11.72B $3.46B $2.41M
Shares (diluted) 193.94M 114.39M 9.96M
Enterprise value $52.25B $9.35B $7.17M

All Metrics

58 metrics · best in bold

Bold marks the best reading: the lowest positive value for multiples, leverage and payout, the highest for everything else. The bar under each value is its percentile against that company's own peers. Hover a value for its rank and the peer median.

Valuation

12 metrics
MetricCORHSICZSTK
P/E 24.3x 23.8x -0.2x
P/FCF 15.5x 16.6x -5.5x
P/Operating cash flow 13.1x 13.5x -5.6x
P/S 0.2x 0.7x 0.8x
P/B 19.5x 2.5x 2.3x
P/Tangible book -23.4x 3.3x 2.3x
EV/EBITDA 17.5x 12.7x -0.1x
EV/EBIT 23.6x 18.8x -0.1x
EV/Revenue 0.2x 0.9x 0.8x
EV/FCF 17.7x 22.4x -5.5x
EV/Operating cash flow 14.9x 18.2x -5.5x
PEG (3Y EPS CAGR) 1.36 49.82 0.00

Growth

14 metrics
MetricCORHSICZSTK
Revenue growth (1Y) 5.1% 6.5% 27.3%
Revenue CAGR (3Y) 9.4% 2.6% -13.1%
Gross profit growth (1Y) 20.0% 6.4% 171.8%
Gross profit CAGR (3Y) 15.0% 3.4% -32.4%
Operating income growth (1Y) 11.1% 6.6% -2,574%
Operating income CAGR (3Y) 9.5% 1.1% -57.0%
Net income growth (1Y) 38.9% 6.0% -1,263%
Net income CAGR (3Y) 16.2% -4.5% -37.3%
EPS growth (1Y) 39.3% 11.1% 24.9%
EPS CAGR (3Y) 17.9% 0.5% 64.4%
Operating cash flow growth (1Y) 176.7% 36.7% 37.6%
Operating cash flow CAGR (3Y) 14.1% 2.3% 23.9%
Free cash flow growth (1Y) 255.7% 50.1% 37.9%
Free cash flow CAGR (3Y) 13.3% 2.3% 25.2%

Profitability

14 metrics
MetricCORHSICZSTK
Gross margin 4.0% 31.3% 13.1%
EBITDA margin 1.2% 7.4% -597.5%
Operating margin 0.9% 5.0% -598.0%
Pretax margin 1.1% 4.1% -436.1%
Net margin 0.8% 3.0% -444.3%
FCF margin 1.2% 4.2% -14.1%
Operating cash flow margin 1.4% 5.1% -14.0%
Return on equity 77.4% 11.0% -702.9%
Return on assets 3.2% 3.8% -505.5%
Return on invested capital 14.4% 7.1% -852.2%
Return on capital employed 12.9% 8.7% -994.1%
Asset turnover 4.0x 1.2x 1.1x
Cash conversion (OCF / net income) 1.8x 1.6x 0.0x
Stock comp / revenue 0.0% 0.3% 13.1%

Financial Health

11 metrics
MetricCORHSICZSTK
Debt / assets 14.0% 30.4% 9.6%
Debt / equity 3.6x 0.9x 0.2x
Net debt / EBITDA 2.2x 3.3x 0.0x
Debt / FCF 2.9x 6.1x -0.4x
Liabilities / assets 96.1% 66.5% 45.1%
Equity / assets 3.9% 33.5% 54.9%
Interest coverage – 4.3x –
Current ratio 0.9x 1.3x 0.9x
Quick ratio 0.5x 0.6x 0.7x
Cash ratio 0.0x 0.0x 0.2x
Altman Z-score 4.66 2.65 -47.01

Shareholder Returns

7 metrics
MetricCORHSICZSTK
Dividend yield 0.7% – –
Net buyback yield 1.6% 7.7% -48.2%
Shareholder yield 2.3% 7.7% -48.2%
Payout ratio (earnings) 17.7% – –
Payout ratio (FCF) 11.5% – –
Dividend growth (1Y) 8.7% – –
Dividend CAGR (3Y) 5.7% – –

Analyst Estimates

Solid lines are reported fiscal-year results; dashed lines are the consensus for the years ahead. Hover a year for the analysts' high and low, and how each result compared with its estimate.

ConsensusCORHSICZSTK
Forward P/E 19.3xFY2026 14.7xFY2026 –
EPS, next fiscal year $17.08FY2026 $5.75FY2026 $-4.29FY2026
EPS growth, next FY +6.7%FY2026 +15.7%FY2026 –
EPS growth, the year after +11.8% +8.2% –
Revenue, next fiscal year $328.56BFY2026 $13.38BFY2026 $31.29MFY2026
Revenue growth, next FY +2.2%FY2026 +1.5%FY2026 -12.3%FY2026
Revenue growth, the year after -0.3% +4.8% -10.3%

Institutional Ownership

13F filings, quarter ended Jun 30, 2026
HoldersCORHSICZSTK
Held by institutions 94.7% 100.0% –
Institutions holding 1,342 564 –
Change in shares held, QoQ +15.7% +2.1% –
Institutions buying 542 245 –
Institutions selling 609 216 –
Buyers to sellers 0.89 1.13 –

Return Correlation

Daily returns, last 12 months

1.00 means two stocks move in lockstep, 0 that they move independently. Pairs below about 0.5 diversify each other.

CORHSICZSTK
COR 1.00 0.26 0.01
HSIC 0.26 1.00 0.10
ZSTK 0.01 0.10 1.00

Add a Peer

Largest companies in the same industry

Related Comparisons

Frequently Asked Questions

Which is bigger, COR, HSIC and ZSTK?

Cencora (COR) is the largest by market capitalisation: Cencora (COR) $63.35B, Henry Schein (HSIC) $9.51B, ZeroStack (ZSTK) $30.48M.

Which stock is cheaper, COR, HSIC and ZSTK?

Henry Schein (HSIC) trades on the lowest price-to-earnings ratio (Cencora (COR) 24.1x, Henry Schein (HSIC) 23.6x, ZeroStack (ZSTK) -0.2x). On next year's consensus earnings, Henry Schein (HSIC) is cheapest (Cencora (COR) 19.3x, Henry Schein (HSIC) 14.7x). A lower multiple can reflect slower expected growth, so read it next to the growth figures.

Which company is growing faster?

ZeroStack (ZSTK) grew revenue fastest over the trailing twelve months: Cencora (COR) +5.1%, Henry Schein (HSIC) +6.5%, ZeroStack (ZSTK) +27.3%.

Which company is more profitable?

Henry Schein (HSIC) has the highest net margin (Cencora (COR) 0.8%, Henry Schein (HSIC) 3.0%, ZeroStack (ZSTK) -444.3%). On return on invested capital, Cencora (COR) leads (Cencora (COR) 14.4%, Henry Schein (HSIC) 7.1%, ZeroStack (ZSTK) -852.2%).

Which stock has performed better?

Over the past year Henry Schein (HSIC) returned the most: Cencora (COR) -0.7%, Henry Schein (HSIC) +32.4%, ZeroStack (ZSTK) -76.5%. Over five years, Cencora (COR) compounded fastest (Cencora (COR) +22.6%/yr, Henry Schein (HSIC) +2.6%/yr, ZeroStack (ZSTK) -75.0%/yr). Returns are price only, before dividends.

Which pays a higher dividend?

Only one of these companies pays a dividend: Cencora (COR) 0.01%, Henry Schein (HSIC) 0.00%, ZeroStack (ZSTK) 0.00%. Henry Schein (HSIC) and ZeroStack (ZSTK) pays no regular dividend.

Which stock is riskier?

By one-year price volatility, Henry Schein (HSIC) has been the steadiest (Cencora (COR) 32.8%, Henry Schein (HSIC) 25.7%, ZeroStack (ZSTK) 170.0%). Volatility measures how widely the price swings, not the risk of the business.

Which is the better stock, COR, HSIC and ZSTK?

There is no single answer; it depends on what you are buying for. On the 12 head-to-head measures on this page, Henry Schein (HSIC) leads on 6. Business Quant does not give investment advice; use the comparison as a starting point for your own research.

Data from SEC filings, exchange prices and consensus estimates, via Business Quant. Percentile scores compare each company with its own peer group, so two companies' scores are each relative to different peers unless you rank against the whole market. Price returns exclude dividends. Nothing on this page is investment advice.